Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Vincristine Vincristine:0.4 mg/m2/day CIV, days 1-4 Drug: Cyclophosphamide Cyclophosphamide, 750 mg/m2/day IV, day 5 Biological: T-Rapa ...

    Clinical Trial last updated 04/28/2016 - 11:28am.

  2. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Alemtuzumab Cyclophosphamide Fludarabine ... with Thiotepa metabolism. Other Name: Thioplex Drug: Cyclophosphamide Cyclophosphamide (Cytoxan) should be infused over one hour. ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  3. RIC Transplant Using Haplo Donors

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... melphalan (140mg/m2) given one time on Day -1. Drug: Cyclophosphamide cyclophosphamide (50mg/kg) given every day starting on ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  4. Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Names: Allogeneic Lymphocytes ALLOLYMPH Drug: Cyclophosphamide Given IV Other ...

    Clinical Trial last updated 05/03/2016 - 10:51am.

  5. Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Associated Drug(s):  Cyclophosphamide Gender:  ... Names: irradiation radiotherapy therapy, radiation Drug: cyclophosphamide Given IV over 1-2 hours every 24 hours on days -3 to ...

    Clinical Trial last updated 05/03/2016 - 11:29am.

  6. Intra-Osseous Co-Transplant of UCB and hMSC

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: cyclophosphamide All patients will receive a single IV dose of 50 mg/kg of ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  7. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Filgrastim ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  8. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Antithymocyte Globulin Cyclophosphamide Phase:  ... Names: Myleran Busulfex IV Drug: Cyclophosphamide Arms A, B and C - Cytoxan will be given as a 1-2 hour ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  9. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... Associated Drug(s):  Cyclophosphamide Mycophenolate Mofetil ... Cell Mobilizer Other Names: AMD3100 Mozobil(R) Drug: cyclophosphamide Given on Day -5 and Day +4 (Day 0 is first stem cell ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  10. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Fludarabine 30 mg/M2 IV on days -6 to -2 Drug: Cyclophosphamide 14.5 mg/kg IV on days -6, -5, 3, 4 Other Name: CTX ...

    Clinical Trial last updated 04/21/2016 - 1:19pm.